The Construction Industry Institute reports that rework can swallow up to 20% of construction costs. In pharma, where GMP ...

IB [email protected] ReiThera to Showcase Innovative Viral Vector Platforms at ESGCT 2025Rome, Italy – September 30 2025 – ReiThera Srl, the Italian leading Contract Development ...

Success requires AI that is customized, regulated, hybrid in its data structure and grounded at the deepest levels of the ...

In India, pharmaceutical education is developing rapidly, entering in a new digital era. As the sector embraces automation, ...

The clinical success of CRISPR-based treatments is fundamentally dependent on sophisticated gRNA targeting systems that ...

Investors who have applied for the Fabtech Technologies IPO can check the share allotment status on the official BSE or NSE ...

Rubicon Research IPO to raise ₹1,377.50 crore, with a price band of ₹461-₹485 per share, closing on October 13.

Pharmaceutical company Rubicon Research is set to raise Rs 1,377.50 crore through its initial public offering (IPO), which ...

Stem cell manufacturing landscape is rapidly advancing, driven by major clinical trial successes and new therapy approvals. A ...

Rubicon Research launches Rs 1,377.5-cr IPO on Oct 9. Price band, OFS details, use of proceeds, and investor allocations.

Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other diseases caused by oxidative stress, today announced that ...

Automobile sales surge in September; Lemon Tree Premier opens in Tirupati; BLS UK Hotels acquires Trefeddian Hotel.